Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-123724
Filing Date
2022-04-27
Accepted
2022-04-27 16:34:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d352067ddefa14a.htm DEFA14A 11717
2 GRAPHIC g352067g0na1.jpg GRAPHIC 189638
3 GRAPHIC g352067g0na2.jpg GRAPHIC 203096
  Complete submission text file 0001193125-22-123724.txt   553713
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33038 | Film No.: 22860258
SIC: 2834 Pharmaceutical Preparations